These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3617161)

  • 1. Overestimation of vancomycin concentrations utilizing fluorescence polarization immunoassay in patients on peritoneal dialysis.
    Morse GD; Nairn DK; Bertino JS; Walshe JJ
    Ther Drug Monit; 1987 Jun; 9(2):212-5. PubMed ID: 3617161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin monitoring in term newborns: comparison of peak and trough serum concentrations determined by high performance liquid chromatography and fluorescence polarization immunoassay.
    Feferbaum R; Kobol Machado JK; de Albuquerque Diniz EM; Okay TS; Santos SR; Ceccon ME; Krebs VL; de Araújo MC; Costa Vaz A
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(5):149-52. PubMed ID: 11781595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease.
    Smith PF; Petros WP; Soucie MP; Copeland KR
    Ther Drug Monit; 1998 Apr; 20(2):231-5. PubMed ID: 9558140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instability of standard calibrators may be involved in overestimating vancomycin concentrations determined by fluorescence polarization immunoassay.
    Morishige H; Shuto H; Ieiri I; Otsubo K; Oishi R
    Ther Drug Monit; 1996 Feb; 18(1):80-5. PubMed ID: 8848826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bioassay, high-performance liquid chromatography, and fluorescence polarization immunoassay for quantitative determination of vancomycin in serum.
    Ristuccia PA; Ristuccia AM; Bidanset JH; Cunha BA
    Ther Drug Monit; 1984; 6(2):238-42. PubMed ID: 6377600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Morse GD; Farolino DF; Apicella MA; Walshe JJ
    Antimicrob Agents Chemother; 1987 Feb; 31(2):173-7. PubMed ID: 3566247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of serum vancomycin concentrations following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis.
    Bailie GR; Eisele G; Venezia RA; Yocum D; Hollister A
    Clin Pharmacokinet; 1992 Apr; 22(4):298-307. PubMed ID: 1606789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in-vitro degradation at 37 degrees C of vancomycin in serum, CAPD fluid and phosphate-buffered saline.
    White LO; Edwards R; Holt HA; Lovering AM; Finch RG; Reeves DS
    J Antimicrob Chemother; 1988 Nov; 22(5):739-45. PubMed ID: 3061999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overestimation of serum vancomycin concentrations using a fluorescence polarization immunoassay (Tdx) in preterm neonates.
    Paap CM; Sharpe GL
    Dev Pharmacol Ther; 1993; 20(3-4):174-9. PubMed ID: 7828450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis.
    Pancorbo S; Comty C
    Nephron; 1982; 31(1):37-9. PubMed ID: 7110474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
    Mounier M; Benevent D; Denis F
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of vancomycin degradation products on therapeutic drug monitoring in patients with end-stage renal disease.
    Somerville AL; Wright DH; Rotschafer JC
    Pharmacotherapy; 1999 Jun; 19(6):702-7. PubMed ID: 10391415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teicoplanin measurement in patients with renal failure: comparison of fluorescence polarization immunoassay, microbiological assay, and high-performance liquid chromatographic assay.
    Awni WM; St Peter WL; Guay DR; Kenny MT; Matzke GR
    Ther Drug Monit; 1991 Nov; 13(6):511-7. PubMed ID: 1837630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay.
    Pfaller MA; Krogstad DJ; Granich GG; Murray PR
    J Clin Microbiol; 1984 Sep; 20(3):311-6. PubMed ID: 6386852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.
    Albin H; Ragnaud JM; Demotes-Mainard F; Vincon G; Wone C
    Eur J Clin Pharmacol; 1986; 30(3):299-302. PubMed ID: 3732364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an automated fluorescence polarization immunoassay for vancomycin.
    Filburn BH; Shull VH; Tempera YM; Dick JD
    Antimicrob Agents Chemother; 1983 Aug; 24(2):216-20. PubMed ID: 6357070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of high-performance liquid chromatography with fluorescence polarization immunoassay for the analysis of vancomycin in patients with chronic renal failure.
    Najjar TA; al-Dhuwailie AA; Tekle A
    J Chromatogr B Biomed Appl; 1995 Oct; 672(2):295-9. PubMed ID: 8581137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Falsely elevated serum vancomycin concentrations in hemodialysis patients.
    Follin SL; Mueller BA; Scott MK; Carfagna MA; Kraus MA
    Am J Kidney Dis; 1996 Jan; 27(1):67-74. PubMed ID: 8546140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
    Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
    Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.
    Blevins RD; Halstenson CE; Salem NG; Matzke GR
    Antimicrob Agents Chemother; 1984 May; 25(5):603-6. PubMed ID: 6732227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.